Benzinga's Top #PreMarket Losers

fell 16.55 percent to $11.60 in pre-market trading after the company issued a weak forecast.

shares dipped 12 percent to $125.00 in pre-market trading after the company reported weaker-than-expected results for the fourth quarter and issued a downbeat forecast.

shares tumbled 8.95 percent to $52.70 in pre-market trading after the company issued a downbeat outlook.

shares declined 4.67 percent to $9.59 in pre-market trading. T2 Biosystems priced offering of 3,500,000 shares at $9.75 per share.

shares fell 4.25 percent to $25.00 in pre-market trading after the company reported an 8 percent drop in its comparable sales for November.